| abstract |
Insulin-producing cells for use in the prevention and / or treatment of diabetes, prediabetes, or insulin resistance in a subject, wherein said insulin-producing cells are introduced into an intracutaneous site in the subject, where they are implants a matrix at said intracutaneous site in the subject to allow neovascularization of the intracutaneous site with the implanted matrix, wherein the matrix comprises a biodegradable polyurethane; thus preventing and / or treating the subject by administering the insulin produced from the cells to the subject. |